tradingkey.logo
tradingkey.logo
Suchen

Prophase Labs Inc

PRPH
Zur Watchlist hinzufügen
0.363USD
0.0000.00%
Handelsschluss 07/02, 13:00ETKurse um 15 Minuten verzögert
1.09MMarktkapitalisierung
VerlustKGV TTM

mehr Informationen über Prophase Labs Inc Unternehmen

ProPhase Labs, Inc. is a biotech, genomics, and consumer products company. The Company is engaged in providing whole genome sequencing solutions, diagnostic development, such as its potentially life-saving test for the early detection of esophageal cancer and a direct-to-consumer marketing platform for OTC dietary supplements. It develops, manufactures, and commercializes health and wellness solutions. Its Diagnostic services segment provides diagnostic information services to a range of customers in the United States, including health plans, third-party payers and government organizations. Its Consumer products segment is engaged in the research, development, manufacture, distribution, marketing and sale of OTC consumer healthcare products and dietary supplements in the United States and provides personal genomics products and services. The Company also develops and markets dietary supplements under the TK Supplement brand, which includes Legendz XL and Triple Edge XL.

Prophase Labs Inc Informationen

BörsenkürzelPRPH
Name des UnternehmensProphase Labs Inc
IPO-datumJan 16, 1984
CEOKarkus (Ted William)
Anzahl der mitarbeiter96
WertpapierartOrdinary Share
GeschäftsjahresendeJan 16
Addresse711 Stewart Ave, Suite 200
StadtNEW YORK
BörseNASDAQ OMX - NASDAQ BASIC
LandUnited States of America
Postleitzahl11530
Telefon12153450919
Websitehttps://www.prophaselabs.com/
BörsenkürzelPRPH
IPO-datumJan 16, 1984
CEOKarkus (Ted William)

Führungskräfte von Prophase Labs Inc

Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Ted William Karkus
Mr. Ted William Karkus
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
321.53K
--
Dr. Louis Gleckel, M.D.
Dr. Louis Gleckel, M.D.
Independent Director
Independent Director
10.38K
--
Mr. Warren Hirsch, CPA
Mr. Warren Hirsch, CPA
Independent Director
Independent Director
--
--
Ms. Carolina Abenante, Esq.
Ms. Carolina Abenante, Esq.
Independent Director
Independent Director
--
--
Mr. Steven M. Plumb, CPA
Mr. Steven M. Plumb, CPA
Fractional Chief Financial Officer
Fractional Chief Financial Officer
--
--
Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Ted William Karkus
Mr. Ted William Karkus
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
321.53K
--
Dr. Louis Gleckel, M.D.
Dr. Louis Gleckel, M.D.
Independent Director
Independent Director
10.38K
--
Mr. Warren Hirsch, CPA
Mr. Warren Hirsch, CPA
Independent Director
Independent Director
--
--
Ms. Carolina Abenante, Esq.
Ms. Carolina Abenante, Esq.
Independent Director
Independent Director
--
--
Mr. Steven M. Plumb, CPA
Mr. Steven M. Plumb, CPA
Fractional Chief Financial Officer
Fractional Chief Financial Officer
--
--

Häufig gestellte Fragen

Wer sind die fünf größten Anteilseigner von Prophase Labs Inc?

Die fünf größten Anteilseigner von Prophase Labs Inc sind: Mr. Ted William Karkus

Wie viele Institutionen halten Anteile an Prophase Labs Inc (PRPH)?

Mit Stand vom 2026Q1 halten 81 Institutionen Anteile an Prophase Labs Inc, mit einem Gesamtmarktwert von etwa 129.97K, was 1.98% der Gesamtanteile entspricht. Im Vergleich zum 2025Q4 ist der institutionelle Aktienbesitz um -543519.00 gestiegen.